ストックスクリーナーアプリを入手
3.03
5.21%
0.15
アフターアワーズ：
2.97
-0.06
-1.98%
前日終値:
$2.88
開ける：
$2.83
24時間の取引高:
151.63K
Relative Volume:
0.05
時価総額：
$37.28M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-4.72%
1か月 パフォーマンス:
+32.89%
6か月 パフォーマンス:
+89.97%
1年 パフォーマンス:
-3.19%
1日の値動き範囲:
$2.825
$3.10
1週間の範囲:
$2.72
$3.27
52週間の値動き範囲:
$1.345
$6.3699
Q 32 Bio Inc Stock (QTTB) Company Profile
QTTB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
3.03 | 35.44M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | Raymond James | Strong Buy |
| 2024-09-11 | 開始されました | Wells Fargo | Overweight |
| 2024-06-17 | 開始されました | Guggenheim | Buy |
| 2024-05-21 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Piper Sandler | Overweight |
| 2023-07-28 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 繰り返されました | BTIG Research | Neutral |
| 2022-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-02-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-12-14 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 開始されました | Chardan Capital Markets | Buy |
| 2019-11-01 | 開始されました | Oppenheimer | Perform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Q 32 Bio Inc (QTTB) 最新ニュース
Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com
Aug Technicals: Can Q32 Bio Inc stock attract ESG capital inflowsQuarterly Profit Review & Verified Momentum Stock Ideas - moha.gov.vn
Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st
Stock Market Recap: Why millennials buy Spire Inc LGR stockInsider Buying & Safe Swing Trade Setups - BỘ NỘI VỤ
Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Q32 Bio Inc. stock a defensive play in 2025Quarterly Profit Report & Accurate Technical Buy Alerts - Newser
Lee Kalowski, Q32 Bio CFO, sells $31k in shares By Investing.com - Investing.com UK
Is Q32 Bio Inc. stock recession proofWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser
Q32 Bio CEO Morrison sells $77870 in stock By Investing.com - Investing.com South Africa
Insider Sell: Lee Kalowski Sells Shares of Q32 Bio Inc (QTTB) - GuruFocus
Lee Kalowski, Q32 Bio CFO, sells $31k in shares - Investing.com
CEO Morrison Sells 22,506 ($77.9K) Of Q32 Bio Inc [QTTB] - TradingView
Synopsys, Moderna, Strategy, Q32 Bio, Wolfspeed: Stocks Making The Biggest Moves Today - MSN
Deal Watch: Akebia Gets Phase II Alopecia Areata Candidate From Cost-Conscious Q32 - Citeline News & Insights
Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - MSN
Nothing is Better Than Q32 Bio Inc (QTTB) stock at the moment - Setenews
Block Trades: Will CGEN stock remain a Wall Street favorite2025 Technical Overview & Consistent Profit Alerts - BỘ NỘI VỤ
QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future - Bitget
Q32 Bio (QTTB) Stock Analysis Report | Financials & Insights - Benzinga
Will Q32 Bio Inc. stock attract ESG investorsTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook - ts2.tech
Q32 Bio Sells Complement Inhibitor ADX-097 - citybiz
Q32 sells rare kidney disease drug to Akebia for $12M up front - BioWorld MedTech
Q32 Bio Inc. (QTTB) Stock: Jumps on Akebia Acquisition of ADX-097 and Extended Runway - parameter.io
QTTB Stock Surges: Market Insight - StocksToTrade
Dow Dips 200 Points; Q32 Bio Shares Jump - inkl
Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - inkl
Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio Deal - marketscreener.com
Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia - Investing.com Nigeria
Q32 Bio sells complement inhibitor Adx-097 - marketscreener.com
Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront - TipRanks
Akebia Therapeutics (AKBA) Acquires Phase 2 Drug from Q32 Bio - GuruFocus
Q32 Bio sells complement inhibitor ADX-097 to Akebia - TipRanks
Q32 Bio Sells ADX-097 to Akebia Therapeutics - TipRanks
Akebia Announces Establishment of Rare Kidney Disease Pipeline - The Manila Times
EBIT per share of Q32 Bio Inc – LSE:0T6G - TradingView
Cash per share of Q32 Bio Inc – LSE:0T6G - TradingView
Q32 Bio Inc.Common Stock (Nasdaq:QTTB) Stock Quote - Markets Financial Content
Form 8-KCurrent report - ADVFN
Layoff Tracker: Novartis Cuts 550 Employees as Swiss Manufacturing Priorities Shift - BioSpace
Q32 Bio Inc. Faces Financial Challenges Amid Development Efforts - MSN
Q 32 Bio Inc (QTTB) 財務データ
Q 32 Bio Inc (QTTB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.31%
0.33%
大文字化:
|
ボリューム (24 時間):